Impact of Medicaid Expansion on Stage at Diagnosis for US Adults with Pancreatic Cancer: a Population-Based Study
Authors:
- 3 January 2023
- journal article
- research article
- Published by Springer Nature in Journal of Racial and Ethnic Health Disparities
- Vol. 10 (6) , 2826-2835
Abstract
Introduction We evaluated whether Medicaid expansion is associated with earlier stage at diagnosis for pancreatic cancer taking into account key demographic, clinical, and geographic factors. Methods We obtained Surveillance, Epidemiology, and End-Results (SEER-18) data on individuals diagnosed with pancreatic cancer from 2007 to 2016 (< 65 years of age). We defined non-metastatic as either local or regional disease (vs. metastatic disease). To estimate the association of Medicaid expansion with pancreatic cancer stage at diagnosis, we used a difference-in-differences model, at the individual level, comparing those from early-adopting states in 2014 to non-early-adopting states. We utilized cluster-robust standard errors and explored the role of demographic factors (race, sex, insurance at diagnosis), clinical indicator (disease in the head of the pancreas), and county characteristics (Urban Influence Code, Social Deprivation Index). Results In the univariable setting, the probability of non-metastatic disease at diagnosis increased by 3.9 percentage points (ppt) for those from Medicaid expansion states post-expansion (n = 36,609). After adjustment for covariates, the ppt was attenuated to 2.7. Of particular note, we observed evidence of interactions with sex and race. The beneficial effect was less pronounced for men (increase in the probability of non-metastatic stage at diagnosis by 2.1ppt) than women (3.6ppt) and non-existent for blacks (− 3.1ppt) compared to whites (4.9ppt) and other races (4.8ppt). Conclusion Medicaid expansion is associated with increased probability of non-metastatic stage at diagnosis for pancreatic cancer; however, this beneficial effect is not uniform across sex and race. This underscores the need to investigate the impact of policy and implementation strategies on pancreatic cancer survival disparities.Keywords
Funding Information
- Scott R. MacKenzie Foundation
- National Institute on Aging (5R33AG056540)
This publication has 11 references indexed in Scilit:
- Association Between Medicaid Expansion and Diagnosis and Management of Colon CancerJournal of the American College of Surgeons, 2020
- Health Insurance Coverage Disruptions and Access to Care and Affordability among Cancer Survivors in the United StatesCancer Epidemiology, Biomarkers & Prevention, 2020
- How the Affordable Care Act (ACA) Has Narrowed Racial and Ethnic Disparities in Insurance Coverage and Access to Health Care, 2013‐18Health Services Research, 2020
- Comparison of Insurance Status and Diagnosis Stage Among Patients With Newly Diagnosed Cancer Before vs After Implementation of the Patient Protection and Affordable Care ActJAMA Oncology, 2018
- Changes in Insurance Coverage and Stage at Diagnosis Among Nonelderly Patients With Cancer After the Affordable Care ActJournal of Clinical Oncology, 2017
- The Racial Divide in State Medicaid ExpansionsJournal of Health Politics, Policy and Law, 2017
- Projecting Cancer Incidence and Deaths to 2030: The Unexpected Burden of Thyroid, Liver, and Pancreas Cancers in the United StatesCancer Research, 2014
- Medicaid Expansion under the Affordable Care Act. Implications for Insurance-related Disparities in Pulmonary, Critical Care, and SleepAnnals of the American Thoracic Society, 2014
- National Failure to Operate on Early Stage Pancreatic CancerAnnals of Surgery, 2007
- Implementing the Institute of Medicine Definition of Disparities: An Application to Mental Health CareHealth Services Research, 2006